Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
1 raison identifiée
Auteur de référence en rhumatologie
21 articles scientifiques publiés — un praticien à la pointe de la recherche
✨ Génération du profil synthétique IA en cours…
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Journal of Korean Neurosurgical Society · 2018
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2005
Abstract We used the SAMP6 osteoporotic mouse to examine the link between marrow osteogenic potential and in vivo cortical bone formation. SAMP6 marrow supported less in vitro osteogenesis than marrow from SAMR1 controls; SAMP6 mice had a corresponding deficit in endocortical mineralizing surface. This marrow/endocortical defect did not affect the periosteum, where SAMP6 mice had normal to enhanced bone formation. Introduction: With aging, there may be a reduction in the number or proliferative capacity of bone marrow osteoprogenitors that may contribute to age-related decreases in bone formation. To examine the link between the ability of the marrow to support osteogenesis and age-related changes in bone formation, we measured in vitro and in vivo indices of osteogenesis in a model of osteoporosis, the senescence-accelerated mouse SAMP6. Materials and Methods: Femora and tibias from SAMP6 and SAMR1 (control) mice were harvested at 2, 4, 6, and 12 months of age (168 bones total). Bone marrow cells were cultured under osteogenic conditions and stained for alkaline phosphatase (ALP) and alizarin red. Dynamic indices of bone formation were assessed histologically from calcein labels. Results: ALP+ and alizarin red-positive areas were significantly less in cultures from SAMP6 bones versus SAMR1 (p < 0.05), indicating less osteogenic potential. For example, SAMP6 tibial cultures had 21% less ALP+ area and 36% less alizarin red-positive area than SAMR1. Marrow from tibias had 2-fold greater osteogenesis than femoral marrow (p < 0.001). SAMP6 mice had a deficit in endocortical mineralizing surface across all age groups (p < 0.05), but no deficit in mineral apposition rate. Last, despite the marrow and endocortical deficits, SAMP6 mice had normal or slightly increased periosteal bone formation, consistent with their larger bone size. Conclusion: SAMP6 bone marrow supports less in vitro osteogenesis than SAMR1, consistent with a lower concentration of marrow osteoprogenitors in SAMP6. SAMP6 mice have less endocortical mineralizing surface than SAMR1 at all ages but no detectable deficit in mineral apposition rate, which suggests a reduction in osteoblast number but normal function. Periosteal bone formation is unimpaired in SAMP6 mice, indicating that the marrow/endocortical defect does not affect the periosteal surface.
Pain research & management · 2019
Objective. Studies regarding the combination of ultrasound and transcutaneous electrical nerve stimulation (TENS) are rarely reported. In this study, we aimed to elucidate the efficacy and safety of a stimulator using low-intensity pulsed ultrasound (LIPUS) combined with TENS in patients with painful knee osteoarthritis (OA). We evaluated the effectiveness of this therapy against pain, physical function, and cartilage regeneration. Moreover, we aim to prove the superiority of the effects of LIPUS combined with TENS therapy compared with only TENS therapy.Methods. Of the 40 included patients, aged 45–85 years with painful knee OA, 20 patients received only TENS therapy and 20 patients received LIPUS combined with TENS therapy for 8 weeks (a total of more than 80 treatment sessions). We evaluated visual analogue scale (VAS), Western Ontario and McMaster Universities (WOMAC) osteoarthritis index, MOS 36-Item Short-Form Health Survey (SF-36), and femoral articular cartilage (FAC) thickness. The evaluation was performed at three visits: visit 1 (V1, pretreatment, within 28 days after screening), visit 2 (V2, posttreatment period 1, ±3 days after treatment), and visit 3 (V3, posttreatment period 2, 21 ± 3 days after treatment).Results. We expected that LIPUS combined with TENS therapy would be superior to only TENS therapy. However, there was no significant difference between the two therapies. In the within-group comparison, both treatments (only TENS therapy and LIPUS with TENS therapy) demonstrated statistical differences from baseline values for pain and physical function outcomes. FAC thickness showed no significant differences after treatment in both groups.Conclusion. The effects of a stimulator using LIPUS with TENS on pain relief and functional improvement were not superior to the only TENS therapy. Cartilage regeneration, which was expected as an additional benefit of LIPUS, was also not significantly evident. Therefore, further investigation is warranted to determine whether the combination therapy is beneficial. This trial is registered withKCT0003883.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Korean journal of neurotrauma · 2023 · Journal Article
Lee BJ, Seok MC, Koo HW, Jeong JH, et al.
Journal of menopausal medicine · 2023 · Journal Article
Kim S, Na Y, Ko M, Park JY, et al.
Journal of back and musculoskeletal rehabilitation · 2022 · Clinical Trial
Jo NG, Ko MH, Won YH, Park SH, et al.
IDCases · 2020 · Journal Article
Lin WC, Chang C, Ko MC, Lin SM
Seminars in neurology · 2019 · Journal Article
Fein AS, Ko MW
Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association · 2009 · Case Reports
Tateiwa T, Shinmura K, Ko M, Mibe J, et al.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2005 · Journal Article
Silva MJ, Brodt MD, Ko M, Abu-Amer Y
Diagnostics (Basel, Switzerland) · 2025 · Case Reports
Lin TS, Tsao TY, Chen SW, Ko MC, et al.
Cutaneous and ocular toxicology · 2012 · Case Reports
Lee WJ, Ko MK, Lee BR
International journal of rheumatic diseases · 2023 · Letter
Tsai YS, Lee YH, Ko MY
Hong Kong medical journal = Xianggang yi xue za zhi · 2016 · Journal Article
Wan KS, Liu CK, Ko MC, Lee WK, et al.
Medicina (Kaunas, Lithuania) · 2024 · Journal Article
Kim YH, Ha KY, Bae HW, Park HY, et al.
Journal of Korean Neurosurgical Society · 2018 · Journal Article
Kim JW, Park SW, Kim YB, Ko MJ
Korean journal of neurotrauma · 2024 · Journal Article
Lee JT, Ko MJ, Lee BJ, Lee YS, et al.
Korean journal of neurotrauma · 2023 · Journal Article
Ko MJ, Lee BJ
Korean journal of neurotrauma · 2024 · Journal Article
Lee JT, Ko MJ, Lee BJ, Lee YS, et al.
International journal of rheumatic diseases · 2023 · Letter
Pai A, Lee YH, Ko MY, Chen PK
Journal of Nippon Medical School = Nippon Ika Daigaku zasshi · 2018 · Case Reports
Hirama A, Mii A, Arakawa Y, Funakoshi T, et al.
Clinical journal of the American Society of Nephrology : CJASN · 2026 · Journal Article
Ang MD, Cheng CY, Tsai WC, Tsai PH, et al.
Journal of bone metabolism · 2015 · Journal Article
Lee DY, Yang JH, Ki CH, Ko MS, et al.
Pain research & management · 2019 · Journal Article
Kim ED, Won YH, Park SH, Seo JH, et al.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery · 2025 · Journal Article
Ko M, Choi C, Han A, Ahn S, et al.